ArticleBlood neoplasia2025
Prospective clinical trials of venetoclax and hypomethylating agents for relapsed BPDCN.
Naveen Pemmaraju et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleBlood neoplasia2025
Naveen Pemmaraju et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.